13th Jan 2016 09:16
LONDON (Alliance News) - Life sciences company Optibiotix Health PLC on Wednesday said it has signed a commercial agreement with KSF Acquisition UK Ltd on its SlimBiome weight management product.
Optibiotix, which is developing products to tackle obesity, high cholesterol and diabetes, said the agreement will provide the funding to assess the benefits of using the SlimBiome product with KSF's weight management dietary programme.
No financial details on the contract were disclosed.
"We are pleased to announce the signing of this commercial agreement with KSF, whose dietary programme is a trusted and well recognised global brand in weight management," said Optibiotix Chief Executive Stephen O'Hara.
Shares in Optibiotix Health were up 0.7% to 82.04 pence.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
OptiBiotix Health